 |
 |
|
|
|
|
|
|
|
| | | |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
1
.
SEC ADMINISTRATIVE PROCEEDING
|
EXTRACTED KEY WORDS
REPORTS RESPONDENTS ANALYST COMMISSION EXCHANGE ACT PROJECTIONS TAKEMOTO WEBSITE CANCEROPTION STOCK REVENUE SECURITIES INTERNET SALES PRICE PURSUANT FINDINGS MATERIAL FACT INVESTOR RELATIONS FIRM INDEPENDENT ANALYST SHARES VIOLATIONS BASIS BUSINESS PURCHASE CEASE DEEMS SETTLEMENT ARIZONA CANCER-RELATED NUTRITIONAL SUPPLEMENTS EXERCISE |
UNITED STATES OF AMERICA
Before the
SECURITIES AND EXCHANGE COMMISSION
SECURITIES ACT OF 1934
Release No.43246 / September 6, 2000
ADMINISTRATIVE PROCEEDING
File No.3-10275
In the Matter of
CancerOption.com, Inc. and
Arnold C. Takemoto
Respondent.
ORDER INSTITUTING PUBLIC CEASE-
AND-DESIST PROCEEDINGS
PURSUANT TO SECTION 21C OF THE
SECURITIES AND EXCHANGE ACT OF
1934, MAKING FINDINGS AND
IMPOSING A CEASE AND DESIST
ORDER
I.
The Securities and Exchange Commission ("Commission") deems it
appropriate to institute public cease-and-desist proceedings against
CancerOption.com, Inc. ("CancerOption") and Arnold C. Takemoto
(together the "Respondents") pursuant to Section 21C of the Securities
Exchange Act of 1934 ("Exchange Act").
In anticipation of the institution of these administrative
proceedings, Respondents have submitted an Offer of Settlement
("Offer"), which the Commission has determined to accept. Solely for
the purpose of these proceedings and any other proceedings brought by
or on behalf of the Commission or in which the Commission is a party,
and without admitting or denying the findings herein, except that they
admit the jurisdiction of the Commission over them and over the
matters set forth herein, Respondents have consented to the entry of
the findings and the imposition of the cease-and-desist order
("Order") as set forth below.
II.
On the basis of this Order and the Offer submitted by Respondents, the
SNIPPETS:
|
|
|
| | | |
|
|
